➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
AstraZeneca
Mallinckrodt
McKinsey
Colorcon

Last Updated: September 27, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 209724


Email this page to a colleague

« Back to Dashboard

NDA 209724 describes BUMETANIDE, which is a drug marketed by Athenex Inc, Hospira, Teva Parenteral, West-ward Pharms Int, Amneal Pharms Co, Heritage Pharma, Rising, Sandoz, Upsher Smith Labs, and Zydus Pharms, and is included in eleven NDAs. It is available from nineteen suppliers. Additional details are available on the BUMETANIDE profile page.

The generic ingredient in BUMETANIDE is bumetanide. There are six drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the bumetanide profile page.
Summary for 209724
Tradename:BUMETANIDE
Applicant:Amneal Pharms Co
Ingredient:bumetanide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 209724
Medical Subject Heading (MeSH) Categories for 209724
Suppliers and Packaging for NDA: 209724
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUMETANIDE bumetanide TABLET;ORAL 209724 ANDA NCS HealthCare of KY, LLC dba Vangard Labs 0615-8393 0615-8393-39 30 TABLET in 1 BLISTER PACK (0615-8393-39)
BUMETANIDE bumetanide TABLET;ORAL 209724 ANDA NCS HealthCare of KY, LLC dba Vangard Labs 0615-8394 0615-8394-39 30 TABLET in 1 BLISTER PACK (0615-8394-39)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Oct 18, 2017TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Oct 18, 2017TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2MG
Approval Date:Oct 18, 2017TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Colorcon
McKesson
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.